Ziosoft offers free 2D/3D software

Article

In the hope of boosting interest in its thin-client visualization system, Ziosoft is providing to the academic and research communities free software for processing 2D and 3D images.

In the hope of boosting interest in its thin-client visualization system, Ziosoft  is providing to the academic and research communities free software for processing 2D and 3D images. The Windows-based software, called zioTerm basic 2D/3D, can be used to review DICOM 3.0-compatible imaging data from CT, MR, PET, ultrasound and X-ray on a local computer connected to the Internet.  The freeware will provide students and researchers experience using Ziosoft’s core 2D/3D software, according to the company, a long-time provider of advanced visualization in Japan that entered the U.S. market only in the last couple years. The zioTerm software can be downloaded from www.ziosoftinc.com.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.